insights_auto
Why is LLY down २.२९%?
Dive Deeperchevron_right
LLY:NYSE
Eli Lilly And Co
US$ १,३५१.१२
arrow_downward
-२.२९%(-३१.६३) 1D
US$ १,३४२.००
arrow_downward
-०.६७% (-९.१२)bedtimeAfter hours
Closed: नोभेम्बर १९, १६:०२:४३ GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LLY...
Open
US$ १,३६९.३८
High
US$ १,३८२.००
Low
US$ १,३४१.४६
Mkt. cap
१२.७१ खरब
Avg. vol.
२८.४७ लाख
Volume
३२.०० लाख
Dividend
०.५१%
Quarterly dividend
US$ १.७३
Ex-dividend date
२०२६ नोभेम्बर १३
P/E ratio
४३.८६
52-wk high
US$ १,४७५.२५
52-wk low
US$ ८५०.५१
EPS
US$ ३०.८१
Beta
०.४०
Shares outstanding
९४.०७ करोड
No. of employees
५० हजार
Open
US$ १,३६९.३८
High
US$ १,३८२.००
Low
US$ १,३४१.४६
Mkt. cap
१२.७१ खरब
Avg. vol.
२८.४७ लाख
Volume
३२.०० लाख
Dividend
०.५१%
Quarterly dividend
US$ १.७३
Ex-dividend date
२०२६ नोभेम्बर १३
P/E ratio
४३.८६
52-wk high
US$ १,४७५.२५
52-wk low
US$ ८५०.५१
EPS
US$ ३०.८१
Beta
०.४०
Shares outstanding
९४.०७ करोड
No. of employees
५० हजार
News stories
From web sources and news partners
Yahoo Finance Australia
·
१ घण्टा पहिले
Jefferies Has Wall Street’s Highest Target on Eli Lilly (LLY). Why?
Zacks
·
२ घण्टा पहिले
Healthcare ETFs Shine as Investors Rotate Out of Tech
The Business Journals
·
३ घण्टा पहिले
Federal judge dismisses Tampa General Hospital's lawsuit against Eli Lilly
Zacks
·
५ घण्टा पहिले
PFE Inks $2.6B Licensing Deal With Chinese Biotech for CAR-T Therapies
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 36 countries. Its products are marketed in approximately 90 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
About Eli Lilly And Co
CEODavid A. Ricks
Employees५० हजार
Founded१८७६
Headquartersइन्डियानापोलिस, इन्डियाना, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Websitelilly.com